UB Paderborn / Katalog / Suche / in CDI

Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial

Annals of internal medicine, 1998-06, Vol.128 (12 Pt 1), p.975

1998

Volltextzugriff (PDF)

Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma

Haematologica (Roma), 2015-05, Vol.100 (5), p.670

2015

Volltextzugriff (PDF)

Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass

Journal of cardiothoracic and vascular anesthesia, 1993, Vol.7 (4), p.410-415

1993

Volltextzugriff (PDF)

Marked Increase in Veno-Occlusive Disease of the Liver Associated With Methotrexate Use for Graft-Versus-Host Disease Prophylaxis in Patients Receiving Busulfan/Cyclophosphamide

Blood, 1992-05, Vol.79 (10), p.2784-2788

1992

Volltextzugriff (PDF)

Diversity of organ site involvement among malignant lymphomas of mucosa-associated tissues

American journal of clinical pathology, 1991-12, Vol.96 (6), p.738-745

1991

Volltextzugriff (PDF)

Diversity of organ site involvement among malignant lymphomas of mucosa-associated tissues

American journal of clinical pathology, 1991-12, Vol.96 (6), p.738-745

1991

Volltextzugriff (PDF)

Carmustine, Ara C, cyclophosphamide and etoposide with autologous bone marrow transplantation in relapsed or refractory lymphoma : a dose-finding study

Bone marrow transplantation (Basingstoke), 1994-10, Vol.14 (4), p.595-600

1994

Volltextzugriff (PDF)

Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients

Bone marrow transplantation (Basingstoke), 1992-10, Vol.10 (4), p.367-372

1992

Volltextzugriff (PDF)

Abciximab-associated profound thrombocytopenia : Therapy with immunoglobulin and platelet transfusion

The American journal of cardiology, 1996-11, Vol.78 (10), p.1161-1163

1996

Volltextzugriff (PDF)

Chemotherapy administration associated errors before and after use of electronic order entry and decision support

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.19528-19528

2007

Volltextzugriff (PDF)

Phase II trial of vinorelbine for relapsed ovarian cancer: a Southwest Oncology Group study

Gynecologic oncology, 2004-12, Vol.95 (3), p.506-512

2004

Volltextzugriff (PDF)

Abciximab-associated profound thrombocytopenia: Therapy with immunoglobulin and platelet transfusion

The American journal of cardiology, 1996, Vol.78 (10), p.1161-1163

1996

Volltextzugriff (PDF)

Pilot trial of prophylactic ursodiol to incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients

Bone marrow transplantation (Basingstoke), 1992, Vol.10 (4), p.367-372

1992

Volltextzugriff (PDF)

Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan/cyclophosphamide

Blood, 1992-05, Vol.79 (10), p.2784-2788

1992

Volltextzugriff (PDF)

Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2018-05, Vol.391 (10135), p.2116-2127

2018

Volltextzugriff (PDF)

OUTREACH: PRELIMINARY SAFETY & EFFICACY RESULTS FROM A PHASE 2 STUDY OF LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN THE NONUNIVERSITY SETTING

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

A first-in-human phase 1, multicenter, open-label study of CB-011, a next-generation CRISPR-genome edited allogeneic anti-BCMA immune-cloaked CAR-T cell therapy, in patients with relapsed/refractory multiple myeloma (CAMMOUFLAGE trial)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS8063-TPS8063

2023

Volltextzugriff (PDF)

P1455: FIRST‐IN‐HUMAN TRIAL OF CB‐010, A CRISPR‐EDITED ALLOGENEIC ANTI‐CD19 CAR ‐T CELL THERAPY WITH A PD‐1 KNOCK OUT, IN PATIENTS WITH RELAPSED OR REFRACTORY B CELL NON‐HODGKIN LYMPHOMA (ANTLER STUDY)

HemaSphere, 2022-06, Vol.6 (Suppl), p.1337-1338

2022

Volltextzugriff (PDF)

The efficacy of duvelisib monotherapy following disease progression on ofatumumab monotherapy in patients with relapsed/refractory CLL or SLL in the DUO crossover extension study

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.7533-7533

2018

Volltextzugriff (PDF)

KD025 for Patients with Chronic Graft-Versus-Host Disease (cGVHD) – Long-Term Follow-up of a Phase 2a Study (KD025-208)

Biology of blood and marrow transplantation, 2020-03, Vol.26 (3), p.S187-S188

2020

Volltextzugriff (PDF)

KD025-208: A Phase 2a Study of KD025 for Patients with Chronic Graft Versus Host Disease (cGVHD) - Pharmacodynamics (PD) and Updated Results

Biology of blood and marrow transplantation, 2019-03, Vol.25 (3), p.S28-S29

2019

Volltextzugriff (PDF)

Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease

Biology of blood and marrow transplantation, 2005-03, Vol.11 (3), p.188-193

2005

Volltextzugriff (PDF)

38 - Initial Results of KD025-208: A Phase 2a Open-Label Clinical Trial of KD025 for Steroid-Dependent Chronic Graft Versus Host Disease (cGVHD)

Biology of blood and marrow transplantation, 2018-03, Vol.24 (3), p.S70-S70

2018

Volltextzugriff (PDF)

Initial Results of KD025-208: A Phase 2a Open-Label Clinical Trial of KD025 for Steroid-Dependent Chronic Graft Versus Host Disease (cGVHD)

Biology of blood and marrow transplantation, 2018-03, Vol.24 (3), p.S70

2018

Volltextzugriff (PDF)

The Effect of Rate of Infusion on Continuous Epidural Analgesia for Labor and Delivery

Obstetric anesthesia digest, 1989-10, Vol.9 (3), p.160-160

1989

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial

Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma

Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass

Marked Increase in Veno-Occlusive Disease of the Liver Associated With Methotrexate Use for Graft-Versus-Host Disease Prophylaxis in Patients Receiving Busulfan/Cyclophosphamide

Diversity of organ site involvement among malignant lymphomas of mucosa-associated tissues

Diversity of organ site involvement among malignant lymphomas of mucosa-associated tissues

Carmustine, Ara C, cyclophosphamide and etoposide with autologous bone marrow transplantation in relapsed or refractory lymphoma : a dose-finding study

Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients

Abciximab-associated profound thrombocytopenia : Therapy with immunoglobulin and platelet transfusion

Chemotherapy administration associated errors before and after use of electronic order entry and decision support

Phase II trial of vinorelbine for relapsed ovarian cancer: a Southwest Oncology Group study

Abciximab-associated profound thrombocytopenia: Therapy with immunoglobulin and platelet transfusion

Pilot trial of prophylactic ursodiol to incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients

Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan/cyclophosphamide

Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial

OUTREACH: PRELIMINARY SAFETY & EFFICACY RESULTS FROM A PHASE 2 STUDY OF LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN THE NONUNIVERSITY SETTING

A first-in-human phase 1, multicenter, open-label study of CB-011, a next-generation CRISPR-genome edited allogeneic anti-BCMA immune-cloaked CAR-T cell therapy, in patients with relapsed/refractory multiple myeloma (CAMMOUFLAGE trial)

P1455: FIRST‐IN‐HUMAN TRIAL OF CB‐010, A CRISPR‐EDITED ALLOGENEIC ANTI‐CD19 CAR ‐T CELL THERAPY WITH A PD‐1 KNOCK OUT, IN PATIENTS WITH RELAPSED OR REFRACTORY B CELL NON‐HODGKIN LYMPHOMA (ANTLER STUDY)

The efficacy of duvelisib monotherapy following disease progression on ofatumumab monotherapy in patients with relapsed/refractory CLL or SLL in the DUO crossover extension study

KD025 for Patients with Chronic Graft-Versus-Host Disease (cGVHD) – Long-Term Follow-up of a Phase 2a Study (KD025-208)

KD025-208: A Phase 2a Study of KD025 for Patients with Chronic Graft Versus Host Disease (cGVHD) - Pharmacodynamics (PD) and Updated Results

Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease

38 - Initial Results of KD025-208: A Phase 2a Open-Label Clinical Trial of KD025 for Steroid-Dependent Chronic Graft Versus Host Disease (cGVHD)

Initial Results of KD025-208: A Phase 2a Open-Label Clinical Trial of KD025 for Steroid-Dependent Chronic Graft Versus Host Disease (cGVHD)

The Effect of Rate of Infusion on Continuous Epidural Analgesia for Labor and Delivery

Suchergebnisse filtern